Silvan Turkcan
Stock Analyst at Citizens JMP
(1.00)
# 3,974
Out of 4,646 analysts
8
Total ratings
62.5%
Success rate
-5.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Silvan Turkcan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IDYA IDEAYA Biosciences | Maintained: Buy | $42 | $36.68 | +14.50% | 1 | Aug 6, 2026 | |
| CNTX Context Therapeutics | Maintained: Buy | $3 | $0.5064 | +492.42% | 1 | Aug 6, 2026 | |
| CRSP CRISPR Therapeutics AG | Maintained: Buy | $80 | $53.99 | +48.18% | 1 | Jul 22, 2026 | |
| FTH Faeth Therapeutics | Initiated Coverage: Buy | $51 | $28.55 | +78.63% | 1 | Jul 20, 2026 | |
| CELC Celcuity | Maintained: Buy | $160 → $177 | $86.60 | +104.39% | 3 | Jul 15, 2026 | |
| HURA TuHURA Biosciences | Initiated Coverage: Buy | $9 | $2.30 | +291.30% | 1 | Apr 27, 2026 |
IDEAYA Biosciences
Aug 6, 2026
Maintained: Buy
Price Target: $42
Current: $36.68
Upside: +14.50%
Context Therapeutics
Aug 6, 2026
Maintained: Buy
Price Target: $3
Current: $0.5064
Upside: +492.42%
CRISPR Therapeutics AG
Jul 22, 2026
Maintained: Buy
Price Target: $80
Current: $53.99
Upside: +48.18%
Faeth Therapeutics
Jul 20, 2026
Initiated Coverage: Buy
Price Target: $51
Current: $28.55
Upside: +78.63%
Celcuity
Jul 15, 2026
Maintained: Buy
Price Target: $160 → $177
Current: $86.60
Upside: +104.39%
TuHURA Biosciences
Apr 27, 2026
Initiated Coverage: Buy
Price Target: $9
Current: $2.30
Upside: +291.30%